Thousands of different rare diseases are known, which affect the lives of some one hundred million people around the globe, but for most of them there is no dedicated treatment. This multidisciplinary project employs new approaches to translate patient-specific genomic data into guides for intervention and development of novel, tailored therapies for the specific mutation. The study is being conducted in cooperation with MIDGAM – the Israeli Biorepository Network for Research.